GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Total Payout Ratio

Stealth BioTherapeutics (Stealth BioTherapeutics) Total Payout Ratio : 0.00 (As of May. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Stealth BioTherapeutics's current Total Payout Ratio is 0.00.


Stealth BioTherapeutics Total Payout Ratio Historical Data

The historical data trend for Stealth BioTherapeutics's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Total Payout Ratio Chart

Stealth BioTherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Payout Ratio
Get a 7-Day Free Trial - - 1.23 0.41 0.17

Stealth BioTherapeutics Quarterly Data
Dec16 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stealth BioTherapeutics's Total Payout Ratio

For the Biotechnology subindustry, Stealth BioTherapeutics's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stealth BioTherapeutics's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's Total Payout Ratio falls into.



Stealth BioTherapeutics Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Stealth BioTherapeutics's Total Payout Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 8.975 + 0) / -52.527
=0.17

Stealth BioTherapeutics's Total Payout Ratio for the quarter that ended in Mar. 2022 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -8.136
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stealth BioTherapeutics Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.

Stealth BioTherapeutics (Stealth BioTherapeutics) Headlines

From GuruFocus

Stealth BioTherapeutics Corp Announces Completion of Merger

By PRNewswire PRNewswire 11-16-2022